Aspirin, beta-blocker and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction

By Berger A.K.   Duval S.   Krumholz H.M.  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 17-17

Elsevier

Access to resources Recommend Favorite

Comparison of Effects of Low Dose of Spironolactone and a Thiazide Diuretic in Patients with Hypertension Treated with an Angiotensin-Converting Enzyme Inhibitor or an Angiotensin Type 1 Receptor Blocker

By Yutaka Miyashita   Mifune Mizuo   Kubota Eiji   Itoh Hiroshi   Saito Ikuo  

Clinical and Experimental Hypertension, Vol. 31, Iss. 8, 2009-12 ,pp. : 648-656

Informa Healthcare

Access to resources Recommend Favorite

Effect of Angiotensin-converting Enzyme Two-week Inhibition on Renal Angiotensin II Receptors and Renal Vascular Reactivity in SHR

By Haddad G.   Garcia R.  

Journal of Molecular and Cellular Cardiology, Vol. 29, Iss. 2, 1997-02 ,pp. : 813-822

Academic Press

Access to resources Recommend Favorite

Lack of Association of Angiotensin-converting Enzyme and Angiotensinogen Genes Polymorphisms with Left Ventricular Structure in Young Normotensive Men

By LINHART ALEŠ   SEDLÁČEK KAMIL   JÁCHYMOVÁ MARIE   JINDRA ANTONÍN   BERAN STANISLAV   VONDRÁČEK VLADIMÍR   HELLER SAMUEL   HORKÝ KAREL  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 47-51

Informa Healthcare

Access to resources Recommend Favorite

A Novel Design of Combining the Angiotensin Converting Enzyme (ACE) Inhibitor Captopril with the Angiotensin Receptor Blocker (ARB) Losartan Using Homo Coupling via PEG Diacid Linker

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 8, Iss. 3, 2013-12 ,pp. : 221-225

Bentham Science Publishers

Access to resources Recommend Favorite